Skip to content

Dividends Paid at other companies

Merck & Co. logo
Merck & Co.MRK
$2.11B+2.7%
Amgen logo
AmgenAMGN
$1.36B+6.2%

Other financials

Income statement

See full
Revenue$3.6B+19.0%
Operating income$642.9M+8.7%
Net income$727.2M-10.1%
EPS (diluted)$6.75-7.2%

Balance sheet

See full
Cash & equivalents$3.0B-4.0%
Total debt$2.7B+0.1%
Total equity$31.4B+6.9%
Total assets$40.9B+8.9%

Cash flow

See full
Operating cash flow$1.1B+3.2%
CapEx$230.6M+0.6%
Free cash flow$848.3M+4.0%

Valuation

See full
Market cap$65.37B+16.2%
Enterprise value$65.11B+14.3%
P/E14.8×+2.2×
P/S4.4×+0.4×

Profitability

See full
Gross margin93.9%
Operating margin24.3%-2.9pp
Net margin29.6%-2.3pp
FCF margin27.6%+5.5pp

Returns & leverage

See full
Return on equity14.5%-1.4pp
Debt / equity0.1×0.0×
Current ratio3.6×-1.4×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDividends.

The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regeneron Pharmaceuticals's dividends paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regeneron Pharmaceuticals's dividends paid?
Regeneron Pharmaceuticals (REGN) reported dividends paid of $97.8M in Q1 2026.
How has Regeneron Pharmaceuticals's dividends paid changed year-over-year?
Regeneron Pharmaceuticals's dividends paid increased by 4.3% year-over-year, from $93.8M to $97.8M.
What does dividends paid mean?
Total cash dividends paid to common stockholders, reflecting the company's capital return policy.